InvestorsHub Logo
Followers 12
Posts 1142
Boards Moderated 0
Alias Born 12/22/2017

Re: None

Saturday, 05/18/2024 2:04:22 PM

Saturday, May 18, 2024 2:04:22 PM

Post# of 3644
Reposted from X:
Rapport Therapeutics filed an S1 on May 17th to go public.

The genesis of Rapport Therapeutics is unequivocally linked to an effort to stop the Cassava Sciences Alzheimer's therapy trial. They seemed to put a competitor through HELL to gain an advantage and profit from a short position in the stock.

David Bredt founded Rapport Therapeutics a Delaware on February 11 2022, the same day that his citizen's petition against $sava was denied by the FDA.

I believe David Bredt,
@JNJNews
, Rapport Therapeutics, Jordan Thomas, and
@ThirdRockV
participated in a massive fraud to stop a competitor in the exact same research area of Receptor Associated Proteins (the RAP in Rapport). David Bredt departed Johnson and Johnson in March of 2021. He worked with Jordan Thomas and filed a Citizen's Petition and Whistleblower complaints against Cassava in August of 2021. The Citizen's Petition was denied on the same day he started Rapport. SEC and DOJ investigations still linger with no charges against $sava. How could that happen if all these events are not linked by collusion between these people and companies?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News